Anthem BiosciencesNSE:ANTHEM -0.96%23 Operating Margin % is 37.26% as of Mar. 2026, which is 13% above its 10-year median of 32.94. GuruFocus rates NSE:ANTHEM with a GF Score™ of 23/100. The stock has 4 warning signs investors should review. Among 944 Biotechnology companies, Anthem Biosciences ranks better than 94.17% on this metric.
The historical rank and industry rank for Anthem Biosciences's Operating Margin % or its related term are showing as below:
NSE:ANTHEM'
s Operating Margin % Range Over the Past 10 Years
Min: 29.92 Med: 32.94 Max: 42.16
Current: 33.75
NSE:ANTHEM's Operating Margin % is ranked better than 94.17% of 944
companies
in the Biotechnology industry
Industry Median: -86.83
vs NSE:ANTHEM: 33.75
Anthem Biosciences's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Anthem Biosciences Operating Margin % Related Terms
Anthem Biosciences Operating Margin % Historical Data
* Premium members only.
The historical data trend for Anthem Biosciences's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ANTHEM vs VRTX, REGN, ALNY: Operating Margin % Comparison
For the Biotechnology subindustry, Anthem Biosciences's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Anthem Biosciences Operating Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Anthem Biosciences's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Anthem Biosciences's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Anthem Biosciences's Operating Margin % for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Anthem Biosciences (NSE:ANTHEM) has a Operating Margin % of 37.26% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Anthem Biosciences and its competitors. This is 13% above median its historical median of 32.94. Over the past decade, Anthem Biosciences' Operating Margin % has ranged from 29.92 to 42.16. According to the industry distribution chart, Anthem Biosciences ranks #55 out of 944 companies in the Biotechnology industry, placing it in the top 5.8%.
Is Anthem Biosciences' Operating Margin % too high?
Anthem Biosciences' current Operating Margin % of 37.26% is 13% above median its 10-year median of 32.94. Over the past 10 years, this metric has ranged from a low of 29.92 to a high of 42.16. Based on the distribution chart, Anthem Biosciences ranks #55 out of 944 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Anthem Biosciences has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Anthem Biosciences' Operating Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Anthem Biosciences ranks #55 out of 944 companies for Operating Margin %. This places Anthem Biosciences in the top 6% of its industry — outperforming the majority of peers. Historically, Anthem Biosciences' own Operating Margin % has ranged from 29.92 to 42.16 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Anthem Biosciences and its competitors. Anthem Biosciences's current Operating Margin % is 37.26%, which is 13% above median its own 10-year median of 32.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anthem Biosciences stock overvalued right now?
Anthem Biosciences (NSE:ANTHEM) has a current Operating Margin % of 37.26%. The current Operating Margin % is 37.26%, which is 13% above median its 10-year median of 32.94. Anthem Biosciences' overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Anthem Biosciences (NSE:ANTHEM), the current Operating Margin % is 37.26% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Anthem Biosciences Ltd is an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (CRDMO) with fully integrated operations spanning across drug discovery, development and manufacturing. It is one of the few companies in India with integrated New Chemical Entity (NCE) and New Biological Entity (NBE) capabilities across drug discovery, development, and commercial manufacturing. As a one-stop service provider, It serves a range of customers, encompassing innovator-focused emerging biotech and large pharmaceutical companies globally.
23GF Score
Get the complete analysis for NSE:ANTHEM
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ANTHEM has been successfully added to your 
